Clinuvel Pharmaceuticals LimitedASX: CUV

Application for quotation of securities - CUV

Oct 5, 2026 at 5:51 PM EDT · Issued by Clinuvel Pharmaceuticals Limited via ASX

Filed with ASX · Oct 5, 2026 at 5:51 PM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-cuv

Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 6Announcement SummaryEntity nameCLINUVEL PHARMACEUTICALS LIMITEDAnnouncement TypeNew announcementDate of this announcementTuesday October 06, 2026The +securities to be quoted are:Total...

View Attachment

6ix hasn’t read this filing yet.

Clinuvel Pharmaceuticals Limited on 6ix

Earlier from Clinuvel Pharmaceuticals

Change in substantial holdingOct 5
Notice of Annual General Meeting/Proxy FormOct 1
New CUV105 vitiligo cases presented to EADVSep 30
Becoming a substantial holderSep 23
CLINUVEL date of Annual General MeetingSep 18

Later from Clinuvel Pharmaceuticals

Notification of cessation of securities - CUVOct 5
Section 708A Cleansing StatementOct 5
CLINUVEL files NEURACTHEL Instant dossierOct 29

All Clinuvel Pharmaceuticals news releases

Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.

Follow Clinuvel Pharmaceuticals